Daily cardiology

Cardio-Watch podcast: Episode 2, Hypertension 15.01.2022 11:14 ↓

The second episode of Cardio-Watch: Hypertension

Impact: DAPT vs. Aspirin in patients with stroke or TIA 15.01.2022 2:18 ↓

A recent meta-analysis about antiplatelet therapy in stroke

Therapeutic anticoagulation with Heparin in critically and non-critically ill patients with COVID-19 15.01.2022 3:44 ↓

The role of Heparin in the management of thrombosis in COVID-19

Cardio-Watch Podcast: Episode 6, Electrophysiology 15.01.2022 8:24 ↓

The sixth episode of Cardio-Watch: Electrophysiology

Effect of Neprilysin Inhibition on LV Remodeling in Asymptomatic LV Systolic Dysfunction After MI 15.01.2022 3:35 ↓

Neprilysin Inhibitors to prevent LV remodeling post MI

A review on four landmark anti-platelet therapy trials 15.01.2022 7:52 ↓

The latest updates on anti-platelet therapy from 4 important trials

Cardio-Watch podcast: Episode 3, Atrial fibrillation and Flutter 15.01.2022 11:41 ↓

The Third episode of Cardio-Watch: AF

Left Atrial Appendage Occlusion to prevent Stroke 15.01.2022 2:50 ↓

Preventing Stroke by surgical LA Appendage Occlusion

Cardio-Watch Podcast: Episode 1, COVID-19 and the heart 15.01.2022 11:28 ↓

The first episode of Cardio-Watch podcast

Cardio-Watch Podcast: Episode 5, cardiometabolic disorders 15.01.2022 9:24 ↓

The fifth episode of Cardio-Watch: cardiometabolic disorders

Impact: No-LVT trial 15.01.2022 2:29 ↓

Comparative study of oral anticoagulation in left ventricular thrombi

Impact: the paradox of physical activity in cardiovascular disease 15.01.2022 2:35 ↓

The contemporary Copenhagen general population study

Safety and Efficacy of different antithrombotic strategies after TAVI 15.01.2022 2:38 ↓

Post-TAVI antithrombotic strategies

Midodrine for the prevention of vasovagal syndrome: a randomized clinical trial 15.01.2022 1:57 ↓

Midodrine in vasovagal syndrome prevention

Long-term event-free and overall survival with Dapagliflozin in HFrEF patients 15.01.2022 2:26 ↓

Impact of Dapagliflozin on the survival of HFrEF patients

Milrinone compared with Dobutamine in cardiogenic shock: DOREMI trial 15.01.2022 1:39 ↓

Milrinone vs. Dobutamine: DOREMI trial

Dapagliflozin in non-DM Patients with HF and Reduced EF 15.01.2022 3:54 ↓

The findings of DAPA-HF trial in non-diabetics

Benefits of Targeting for a 15.01.2022 2:30 ↓

The findings of TST study

Electrical versus pharmacological cardioversion for acute AF in emergency settings 15.01.2022 2:24 ↓

The findings of RAFF2 trial

Daily Cardiology Journal Club: First Session – How to setup an effective Journal Club? 15.01.2022 45:48 ↓

Monthly Case-Based Clinical Problem Solving

Dapagliflozin in concurrent Atrial Fibrillation and T2DM 15.01.2022 1:38 ↓

Insights from DECLARE-TIMI 58 Trial

Daily Cardiology Journal Club: First Session – How to setup an effective Journal Club? 15.01.2022 45:48 ↓

Monthly Case-Based Clinical Problem Solving

Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial 15.01.2022 59:55 ↓

Monthly Case-Based Clinical Problem Solving

Predicting the Risk of Post-stroke Atrial Cardiopathy 15.01.2022 2:04 ↓

An interim analysis from ACARDIA trial

Intensive LDL lowering beyond current recommendations for MACE prevention 15.01.2022 2:47 ↓

A meta-analysis of RCTs